Switch to:
More From Other Websites
With A $1.2 Billion Hammer, The FTC Closes Loophole To Prevent Generic Drugs May 28 2015
Teva Buying Mylan Stock May Portend Showdown at Investor Meeting May 28 2015
Teva increases pressure on $40bn takeover target Mylan May 27 2015
After-hours buzz: Palo Alto, Teva, Analog & more May 27 2015
Mylan to Present at the Bernstein Strategic Decisions Conference May 26 2015
Exclusive: Mylan chairman says Teva offers nothing we can't do on our own May 26 2015
Five things to know today, and why Mylan NV didn't take a holiday May 26 2015
2:07 am Mylan Labs issues clarification Irish Takeover Panel relating to its intention to acquire... May 26 2015
Mylan/Perrigo Clarification May 25 2015
Dealpolitik: Why Lawyers Need to Care About the Mylan-Kirkland Battle May 22 2015
How Much is Actavis Worth? A Lot More Than It is Now May 22 2015
Law Firm Advising Teva Dismisses Mylan Objections May 21 2015
Theravance Biopharma Presents Additional Positive Phase 2b Study Data on TD-4208 May 20 2015
Five things to know today, and a big golden parachute in Heinz merger May 19 2015
Endo Buying Par Pharma To Become Top Generics Player May 18 2015
Endo pushes further into generics with $8 billion Par Pharma buy May 18 2015
Endo pushes further into generics with $8 bln Par Pharma buy May 18 2015
Perrigo CEO Says Ready to Talk Deal With Mylan at Right Price May 18 2015
Growing 29% YTD, Cross-Border M&As Near $594 Billion May 14 2015
Dealpolitik: 2015 May Be an Expensive Tax Year for Some Mylan Shareholders May 13 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK